22157.jpg
AAV Vectors in Gene Therapy Pipeline Landscape Report 2024: Comprehensive Insights about 70+ Companies and 235+ Pipeline Drugs
19 avr. 2024 07h31 HE | Research and Markets
Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "AAV vectors in gene therapy - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "AAV vectors in gene...
MDA and FARA Announce Collaboration Research Grant for Friedreich's Ataxia
Muscular Dystrophy Association and Friedreich’s Ataxia Research Alliance Announce Collaborative Research Grant Using Novel Gene Editing Technology to Address Root Cause of Friedreich’s Ataxia Disease
17 avr. 2024 09h00 HE | Muscular Dystrophy Association
New York, April 17, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) and Friedreich’s Ataxia Research Alliance (FARA) announced today a collaborative grant for $300,000 awarded to...
GENE logo.png
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
16 avr. 2024 08h00 HE | Genetic Technologies Ltd
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
GENE logo.png
GTG to pilot GeneType in Breast Screen centers across the U.S.
11 avr. 2024 08h00 HE | Genetic Technologies Ltd
Genetic Technologies to pilot GeneType in Breast Screen centers across the U.S.
GENE logo.png
GTG Global Collaborations and Innovation Update
26 mars 2024 08h00 HE | Genetic Technologies Ltd
GTG Global Collaborations and Innovation Update
GENE logo.png
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
25 mars 2024 08h00 HE | Genetic Technologies Ltd
MELBOURNE, Australia, March 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, “Company”, “GENE”), a global leader in guideline-driven genomics-based testing in health, wellness...
GENE logo.png
GTG to launch U.S. Customer Digital Media Sales Campaign
28 févr. 2024 08h00 HE | Genetic Technologies Ltd
MELBOURNE, Australia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, “Company”, “GTG”), is pleased to announce the launch of a wide-reaching customer – targeted...
22157.jpg
Global Paternity & Relationship Testing Services Market Forecast to Skyrocket by 2027 with Advances in Direct-to-Consumer Genetic Technologies
26 févr. 2024 03h44 HE | Research and Markets
Dublin, Feb. 26, 2024 (GLOBE NEWSWIRE) -- The "Paternity & Relationship Testing Services. Global Market Forecasts for Applications and Technologies with Executive and Consultant Guides. 2023 to...
GENE logo.png
Launching our most comprehensive test and expanding into new global markets
31 janv. 2024 08h00 HE | Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE), is at the forefront in personalised predictive genomics, reshaping the healthcare landscape with...
22157.jpg
Global Optogenetics Market Report 2024-2033: Emerging Trends in Tools & Technologies, Pharma Collaborations, Drug Discovery & Development Integration, and Non-Neural Cell Type Applications
18 janv. 2024 06h53 HE | Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Optogenetics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global optogenetics market has grown rapidly in...